Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 1 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | — | 1 | — | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | — | 1 | — | — | — | 1 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 1 | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | — | 1 | — | — | — | 1 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | 1 | — | — | — | 1 |
Drug common name | Tozadenant |
INN | tozadenant |
Description | Tozadenant is a member of benzothiazoles. |
Classification | Small molecule |
Drug class | adenosine receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12 |
PDB | — |
CAS-ID | 870070-55-6 |
RxCUI | — |
ChEMBL ID | CHEMBL2105747 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB12203 |
UNII ID | D9K857J81I (ChemIDplus, GSRS) |